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Benzothieno[3,2-b]quinoline 1 and benzothieno[2,3-c]quinoline 2 are 
known for their anti-plasmodic and anti-infectious activities, acting mainly 
through intercalation between DNA base pairs when used in their salt form [1]. 
Normally synthesized by two separated reactions, our group was able to obtain 
the two compounds in a single reaction. 
In this work, we present fluorescence studies of compounds 1 and 2 in 
several solvents and when incorporated in lipid membranes of dipalmitoyl 
phosphatidylcholine (DPPC), dimyristoyl phosphatidylethanolamine (DMPE), 
egg yolk phosphatidylcholine (Egg-PC) and dioctadecyldimethylammonium 
bromide (DODAB). The fluorescence 
emission of both compounds shows a 
completely loss of vibrational structure 
and a pronounced red shift in polar 
solvents (48 nm and 28 nm between 
cyclohexane and water for compound 1 
and 2, respectively), indicating that 
these compounds may be used as 
solvatochromic probes. 
Fluorescence anisotropy measurements of the benzothienoquinolines 
encapsulated in liposomes indicate that both compounds are located inside the 
lipid bilayer, feeling the penetration of some water molecules. Compound 2 
generally prefers a less hydrated environment. Upon transition from the gel 
phase to the liquid-crystalline phase in DMPE and DODAB vesicles, a change in 
location of both compounds to more hydrated environments is observed, 
especially for compound 1. These studies may be important to future drug 
delivery applications of these potential biologically-active compounds using 
liposomes in order to reduce toxic effects or to increase drug circulation time [2]. 
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Figure 1. Structure of compounds 1 and 2. 
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